Abstract
The allegation that vaccines cause cancer pits science and evidence against Internet mythology and out-of-context information. Theories espoused on the Internet flourish suggesting a link between rises in cancer rates with an increase in the distribution of vaccines. None of the theories are based on scientific evidence. Every day we know more about what actually causes cancer, how vaccines can prevent cancer and sometimes even treat cancer, and how vaccines are studied carefully for any adverse effects and continue to be improved. This chapter will describe the infectious causes of cancers, discuss vaccines that can prevent infections and thereby prevent cancer, describe vaccines used to treat cancer, and finally, provide facts to dispute the controversies and myths associating vaccines with the development of cancers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Porta C, Riboldi E, Sica A. Mechanisms linking pathogens-associated inflammation and cancer. Cancer Lett. 2011;305:250–62.
Vatanasapt V, Uttaravichien T, Mairiang E-O, et al. Cholangiocarcinoma in north-east Thailand. Lancet. 1990;335:116–7.
Kim HG, Han J, Kim M-H, et al. Prevalence of clonorchiasis in patients with gastrointestinal disease: a Korean nationwide multicenter survey. World J Gastroenterol. 2009;15:86–94.
Mostafa MH, Sheweita SA, O’Connor PJ. Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev. 1999;12:97–111.
Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295–300.
Sarid R, Gao SJ. Viruses and human cancer: from detection to causality. Cancer Lett. 2011;305:218–27.
Bouvard V, Baan R, Straif K, et al. A review of human carcinogens-part B: biological agents. Lancet Oncol. 2009;10:321–2.
Bouchard MJ, Navas-Martin S. Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges. Cancer Lett. 2011;305:123–43.
Bosch FX, Lorincz A, Meijer CJLM, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244–65.
Walboomers JMM, Jacobs MV, Manos MM, et al. Human papilloma-virus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12–9.
Korzeniewski N, Spardy N, Duensing A, Duensing S. Genomic instability and cancer: lessons learned from human papillomaviruses. Cancer Lett. 2011;305:113–22.
Garland SM. Human papillomavirus update with a particular focus on cervical disease. Pathology. 2002;34:213–24.
Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med. 1995;332:1186–91.
Shah KV. SV40 and human cancer: a review of recent data. Int J Cancer. 2007;120:215–23.
Franco EL, Harper DM. Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control. Vaccine. 2005;23:2388–94.
Villa LL. HPV prophylactic vaccination: the first years and what to expect from now. Cancer Lett. 2011;305:106–12.
Ma B, Xu Y, Hung C-F, Wu T-C. HPV and therapeutic vaccines: where are we in 2010? Curr Cancer Ther Rev. 2010;6:81–103.
Trunz BB, Fine PEM, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet. 2006;367:1173–80.
Zbar B, Rapp HJ. Immunotherapy of guinea pig cancer with BCG. Cancer. 1974;34:1532–40.
Morales A, Eidinger D, Bruce AW. Intracavitary bacillus Calmette-Guérin in the treatment of superficial bladder tumors. J Urol. 1976;116:180–3.
Sylvester RJ. Bacillus Calmette-Guérin treatment of non-muscle invasive bladder cancer. Int J Urol. 2011;18:113–20.
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300.
Luo Y, Henning J, O’Donnell MA. Th1 cytokine-secreting recombinant Mycobacterium bovis bacillus Calmette-Guérin and prospective use in immunotherapy of bladder cancer. Clin Dev Immunol. 2011;2011:728930.
Gontero P, Bohle A, Malmstrom P-U, et al. The role of bacillus Calmette-Guerin in the treatment of non-muscle-invasive bladder cancer. Eur Urol. 2010;57:410–29.
Diaz JA, Griffith RA, Ng JJ, Reinert SE, Friedmann PD, Moulton AW. Patients’ use of the internet for medical information. J Gen Intern Med. 2002;17:180–5.
Betsch C, Sachse K. Dr. Jekyll or Mr. Hyde? (How) the internet influences vaccination decisions: recent evidence and tentative guidelines for online vaccine communication. Vaccine. 2012;30:3723–6.
Cantwell A. Cancer-causing vaccines, Polio, AIDS, and monkey business. http://rense.com/general54/Cancer-causing_vaccinesR.htm (2012). Accessed 27 Feb 2012.
Vaccines cause cancer: from hell to veins. http://gdsajj.wordpress.com/2010/06/27/vaccines-cause-cancer. http://orbisvitae.com/ubbthreads/ubbthreads.php?ubb=showflat&Number=53487 (2012). Accessed 27 Feb 2012.
Tanner R. Do vaccines cause cancer? Cancerous cell lines used in the development of vaccines. http://orbisvitae.com/ubbthreads/ubbthreads.php?ubb=showflat&Number=53487 (2012). Accessed 27 Feb 2012.
Goldmacher VS, Thilly WG. Formaldehyde is mutagenic for cultured human cells. Mutat Res. 1983;116:417–4122.
Ragan DL, Boreiko CJ. Initiation of C3H/10T1/2 cell transformation by formaldehyde. Cancer Lett. 1981;13:325–31.
Offit PA, Jew RK. Addressing parent’s concerns: do vaccines contain harmful preservatives, adjuvants, additives, or residuals? Pediatrics. 2003;122:1394–401.
Epidemiology of chronic occupational exposure to formaldehyde: report of the ad hoc panel on health aspects of formaldehyde. Toxicol Ind Health. 1988;4:77–90.
Til HP, Woutersen R, Feron VJ, et al. Two-year drinking-water study of formaldehyde in rats. Food Chem Toxicol. 1989;27:77–87.
van der Kuyl AC, Cornelissen M, Berkhout B. Of mice and men: on the origin of XMRV. Front Microbiol. 2011;1:1–7.
Miyazawa T. Endogenous retroviruses as potential hazards for vaccines. Biologicals. 2011;38:371–6.
Eddy B, Borman G, Berkeley W, Young R. Tumors induced in hamsters by injection of rhesus monkey kidney cell extracts. Proc Soc Exp Biol Med. 1961;107:191–7.
Butel JS, Lednicky JA. Cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst. 1999;91:119–34.
Carbone M, Rizzo P, Pass HI. Simian virus 40, polio vaccines and human tumors: a review of recent developments. Oncogene. 1997;15:1877–88.
Strickler HD, Rosenberg PS, Devesa SS, et al. Contamination of poliovirus vaccines with simian virus 40 (1955–1963) and subsequent cancer rates. JAMA. 1998;279:292–5.
Olin P, Giesecke J. Potential exposure to SV40 in polio vaccines used in Sweden during 1957: no impact on cancer incidence rates 1960 to 1993. Dev Biol Stand. 1998;94:227–33.
Carroll-Pankhurst C, Engles EA, Strickler HD, et al. Thirty-five year mortality following receipt of SV40-contaminated polio virus vaccine during the neonatal period. Br J Cancer. 2001;85:1295–7.
Engels EA, Rodman LH, Frisch M, et al. Childhood exposure to simian virus 40-contaminated poliovirus vaccine and risk of AIDS-associated non-Hodgkin’s lymphoma. Int J Cancer. 2003;106:283–7.
Rollison DE, Page WF, Crawford H, et al. Case–control study of cancer among US Army veterans exposed to simian virus 40-contaminated adenovirus vaccine. Am J Epidemiol. 2004;160:317–24.
National Research Council. Immunization safety review: SV40 contamination of polio vaccine and cancer. Washington, DC: The National Academies Press; 2002.
Poulin DL, DeCaprio JA. Is there a role for SV40 in human cancer. J Clin Oncol. 2006;24:4356–65.
Lopez-Rios F, Illei PB, Ladanyi M. Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids. Lancet. 2004;364:1157–66.
Silverman RH, Nguyen C, Weight CJ, Klein EA. The human retrovirus XMRV in prostate cancer and chronic fatigue syndrome. Nat Rev Urol. 2010;7:392–402.
Paprotka T, Delviks-Frankenberry KA, Cingoz O, et al. Recombinant origin of the retrovirus XMRV. Science. 2011. www.scienceexpress.org/31May2001/page1/10.1126/science.1205292
Switzer WM, Zheng H, Simmons G, et al. No evidence of murine leukemia virus-related viruses in live attenuated human vaccines. PLoS One. 2011;6:e29223.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Nyquist, AC. (2013). Can Vaccines Cause Cancer?. In: Chatterjee, A. (eds) Vaccinophobia and Vaccine Controversies of the 21st Century. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7438-8_13
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7438-8_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7437-1
Online ISBN: 978-1-4614-7438-8
eBook Packages: MedicineMedicine (R0)